Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/18
End: 07/30/18
Due: 07/30/19
Phase: N/A
Priority: Normal
Start: 01/25/22
End: 06/01/22
Due: 06/01/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks | NCT03931239 | Vabiotech | user2@example.com | None | 2018-03-01 | 2018-07-30 | 2019-07-30 | - | - | 2025-07-14 |
| Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age | NCT05140720 | Vabiotech | user2@example.com | None | 2022-01-25 | 2022-06-01 | 2023-06-01 | - | - | 2025-07-14 |